Ask Me Anything: Non-Hodgkin Lymphoma Updates

Experts Share Non-Hodgkin Lymphoma Updates

In this installment of our Answers Now series, two cancer experts and Patient Power co-founder Andrew Schorr discuss the current treatment landscape for each subtype of non-Hodgkin lymphoma and the new targeted therapies that are emerging from research and clinical trials. The experts also weigh in on the Covid booster shot, whether to pursue an antibody test, and what precautions are still important for the immunocompromised. Stephen Ansell, MD, PhD, is a Professor of Medicine in the Department of Hematology at the Mayo Clinic. Loretta Nastoupil, MD, is an Associate Professor in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at the MD Anderson Cancer Center.

Support for this program has been provided by Bristol-Myers Squibb. Patient Power maintains complete editorial control and is solely responsible for program content.

This article was originally published September 21, 2021 and most recently updated September 22, 2021.
© 2024 HealthCentral LLC. All rights reserved.

More on Non-Hodgkin Lymphoma